Gen-Probe Incorporated (GPRO) to Present at Small and Mid Cap Growth Conference February 15

Gen-Probe Incorporated (NASDAQ:GPRO) will speak at the Small and Mid Cap Growth Conference on February 15 at 10:00 am.

Gen-Probe develops, manufactures and markets nucleic acid probe based products to be used for the clinical diagnosis of human diseases and to screen donated human blood.  The nucleic acid probes are also used to detect harmful organisms in the environment and in industrial processes.

The company markets at sells its products directly within the United States and through distributors worldwide.  Their clientele includes clinical laboratories, public health institutions and hospitals in the United States, Canada and certain countries in Europe.

Gen-Probe products are distributed worldwide under the Vaccines and Diagnostics name of Novartis AG (NYSE:NVS).

For more Conference Call related events or to post your own event, visit:

http://events.finditt.com/Events_List.aspx?catid=12